Inmune Bio Stock Investor Sentiment

INMB Stock  USD 9.22  0.16  1.77%   
About 56% of all INmune Bio's investors are looking to take a long position. The analysis of the overall investor sentiment regarding INmune Bio suggests that some traders are interested. The current market sentiment, together with INmune Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use INmune Bio stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at globenewswire.com         
INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update
Macroaxis News: globenewswire.com
over six months ago at news.google.com         
INmune Bio Stock Price Down 0.2 percent - MarketBeat
Google News at Macroaxis
over six months ago at finance.yahoo.com         
INmune Bio Inc. to Report First Quarter 2024 Financial Results and Provide a Corporate Update on Thu...
Yahoo News
over six months ago at www.macroaxis.com         
Acquisition by Xencor Inc of 192532 shares of INmune Bio at 17.14 subject to Rule 16b-3
Macroaxis News
over six months ago at seekingalpha.com         
INmune Bio files for 250M mixed shelf offering
seekingalpha News
over six months ago at seekingalpha.com         
INmune Bio provides update on Alzheimers candidate XPro
seekingalpha News
over six months ago at investing.com         
Alzheimers patients show stable cognition with INmune Bios XPro
Investing News at Macroaxis
over six months ago at finance.yahoo.com         
INmune Bio Inc. Completes First Cohort and Initiates Second Cohort of Phase 12 Study of INKmune Natu...
Yahoo News
over six months ago at finance.yahoo.com         
INmune Bio Independent Director Acquires 80 percent More Stock
Yahoo News
over six months ago at simplywall.st         
Insider Spends US246k Buying More Shares In INmune Bio
Simply Wall St News at Macroaxis
over six months ago at investing.com         
INmune Bio announces stock and warrant offering
Investing News at Macroaxis
over six months ago at finance.yahoo.com         
INmune Bio Inc. Announces 9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq R...
Yahoo News
over six months ago at globenewswire.com         
INmune Bio Inc. Announces 9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq R...
Macroaxis News: globenewswire.com
over six months ago at finance.yahoo.com         
INmune Bio Inc. Announces 24-Month Stability Validation of XPro for Phase III Readiness and Commerci...
Yahoo News
over six months ago at investing.com         
INmune Bio progresses toward Phase III trials for Alzheimers treatment
Investing News at Macroaxis
Far too much social signal, news, headlines, and media speculation about INmune Bio that are available to investors today. That information is available publicly through INmune media outlets and privately through word of mouth or via INmune internal channels. However, regardless of the origin, that massive amount of INmune data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of INmune Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of INmune Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to INmune Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive INmune Bio alpha.

INmune Bio Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for INmune Stock analysis

When running INmune Bio's price analysis, check to measure INmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INmune Bio is operating at the current time. Most of INmune Bio's value examination focuses on studying past and present price action to predict the probability of INmune Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INmune Bio's price. Additionally, you may evaluate how the addition of INmune Bio to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing